Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: RCT of an Acceptance-based Behavior Therapy for GAD [NA]
This document reports the completion of a randomized controlled trial evaluating Acceptance-based Behavior Therapy for Generalized Anxiety D…
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects [Phase 4]
Phase 4 clinical trial update from Massachusetts General Hospital evaluating stress reduction techniques on anxiety and related neuroendocri…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder [Phase 4]
Phase 4 trial evaluating safety and efficacy of pregabalin (Lyrica) in generalized anxiety disorder has completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders [Phase 2, Phase 3]
This document reports the results of cognitive-behavioral therapy for anxiety disorders in children with autism spectrum disorders across Ph…
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Anxiety in Recovering Opiate Dependence [Phase 4]
Phase 4 trial evaluating anxiety in people recovering from opioid dependence. The study was terminated and results were posted in 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study) [NA]
A completed clinical trial update (INSULA study) from UC San Diego examining neural functioning underlying anxiety and its treatment, focusi…
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder [Phase 3]
A 10-week Phase 3 trial evaluating the efficacy and safety of PD 0332334 for Generalized Anxiety Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) [Phase 3]
A 52-week open-label safety study of PD 0332334 in subjects with Generalized Anxiety Disorder was terminated, according to the clinical tria…
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3) [Phase 3]
Pfizer reports termination of a 10-week Phase 3 trial evaluating PD 0332334 for generalized anxiety disorder.
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2) [Phase 3]
Pfizer's Phase 3 study of PD 0332334 in Generalized Anxiety Disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1) [Phase 3]
Pfizer terminated a Phase 3 trial evaluating PD 0332334 for generalized anxiety disorder.
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy. [Phase 3]
Phase 3 randomized trial evaluating risperidone added to standard therapy versus placebo in adults with generalized anxiety disorder who res…
-
CLINICAL_TRIALS trial_result · 2012-06-29Clinical Trial Update: The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia [Phase 4]
A Phase 4 trial evaluated the effects of eszopiclone and escitalopram (Lexapro) on prefrontal glutamate and GABA in adults with depression w…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD) [Phase 4]
Phase 4 trial update evaluating cognitive-behavioral therapy combined with escitalopram for Generalized Anxiety Disorder.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain [NA]
This completed clinical trial assessed whether stress-reduction interventions affect brain function and structure in individuals with Genera…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: Efficacy of Treatment for Generalized Anxiety Disorder
A completed clinical trial evaluating the efficacy of a treatment for generalized anxiety disorder.
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School Settings [Phase 2]
Phase 2 trial update noting the completion of a modular cognitive behavioral therapy program for treating child anxiety disorders in element…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder [Phase 4]
Phase 4 clinical trial evaluating the safety and efficacy of eszopiclone in patients with generalized anxiety disorder, including those with…
-
CLINICAL_TRIALS trial_result · 2011-09-09Clinical Trial Update: Virtual Reality as Anxiety Management Tool for Generalized Anxiety Disorder [NA]
A completed clinical trial evaluating the use of virtual reality as an anxiety management tool for generalized anxiety disorder.
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: PHARMO Institute Seroquel Safety Study
A completed PHARMO Institute safety study evaluating Seroquel (quetiapine) across schizophrenia, major depressive disorder, bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
This completed clinical trial evaluated changes in metabolic parameters in patients with major depressive disorder, generalized anxiety diso…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Escitalopram in Patients With Generalized Anxiety Disorder [Phase 4]
Phase 4 clinical trial update showing results for escitalopram in adults with Generalized Anxiety Disorder; the study has completed and resu…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD) [Phase 2]
A Phase 2 proof-of-concept trial of AZD7325 in generalized anxiety disorder has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder [Phase 3]
Phase 3 trial evaluating efficacy and safety of Saredutant in Generalized anxiety disorder completed in North America.
-
CLINICAL_TRIALS trial_result · 2011-04-05Clinical Trial Update: Generalized Anxiety Disorder Adjunct Study [Phase 3]
Phase 3 trial results for an adjunctive therapy in generalized anxiety disorder have been completed and posted.